Drug Complications on the Lungs
Recent studies indicate that the use of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) in the early stages of treating acute lower respiratory tract infections may negatively affect treatment outcomes. Research has shown that patients taking these painkillers may be at higher risk of developing serious complications. These complications include the formation of cavities and lung abscesses, as well as an increased risk of bacterial bacteremia. This article aims to review the details of these studies and clarify the potential effects of using painkillers in the treatment of pneumonia. It also seeks to raise awareness among patients and physicians regarding the importance of early diagnosis and appropriate treatment.
The study examined data from 6,200 patients, highlighting the role of medications in the development of interstitial lung disease years later, which can cause breathing difficulties, infections, and fibrosis, resulting in 4.1 to 12.4 million cases worldwide annually. John Waterston, a professor at the University of Manchester, stated, “This area has not been fully explored; we can say that the side effects of certain drugs on the lungs are more widespread than previously thought.” He added, “We know they affect a number of people, which is why we need to develop imaging tests to detect any lung problems before the condition becomes critical.” Waterston emphasized, “It is important to stress that patients can continue taking their medications safely, but it is crucial to consult a doctor immediately if any lung-related side effects occur.”
Researchers drew attention to the need for physicians to be aware of potential pulmonary toxicities and damage caused by certain drugs, thereby increasing focus on newly marketed medications and understanding their side effects.
Recent studies indicate that the use of analgesics and non-steroidal anti-inflammatory drugs (NSAIDs) in the early stages of treating acute lower respiratory tract infections may negatively affect treatment outcomes. Research has shown that patients taking these painkillers may be at higher risk of developing serious complications. These complications include the formation of cavities and lung abscesses, as well as an increased risk of bacterial bacteremia. This article aims to review the details of these studies and clarify the potential effects of using painkillers in the treatment of pneumonia. It also seeks to raise awareness among patients and physicians regarding the importance of early diagnosis and appropriate treatment, and to pay attention to the symptoms of certain drugs due to allergies from the first dose or their complications, which are almost known in patients with heart or lung diseases or those with inflammatory kidney conditions. These symptoms are not necessarily caused by pneumonia or asthma. In the event of shortness of breath, recurrent coughing, or decreased blood oxygen levels, the symptoms may be due to the patient’s sensitivity to a medication they are using, its complications, or incorrect usage methods, which are often followed by elderly patients without supervision, where all types of medications are taken at once.
For example, some anti-inflammatory drugs for urinary tract or prostate infections (such as Uvamin Nitrofurantoin) can cause these symptoms associated with Drug-Induced Interstitial Lung Disease (DIILD). Similarly, beta-blockers used to regulate heart rate and lower high blood pressure, such as Concor, Inderal, Tenormin, and Librax, may have effects, although it is rare for these drugs to cause rupture or damage to lung tissue or fibrosis.
Some anti-inflammatory drugs have reverse effects on the lungs, causing symptoms resembling asthma, nasal tissue swelling, and sinus congestion. Aspirin, which has analgesic, blood-thinning, and anti-inflammatory properties (but is not an antibiotic), affects 10–14% of asthma patients with its complications, causing similar symptoms that resolve upon discontinuation of the drug. Methotrexate, used as a painkiller for autoimmune joint pains such as rheumatoid arthritis or psoriasis, or other skin diseases, causes reverse symptoms resembling hypersensitivity, lung inflammation, and breathing difficulties in some patients.
Most chemotherapy medications cause shortness of breath and reverse effects on the kidneys, and pain if the patient does not already complain of kidney diseases. However, if the patient has a history of kidney stones, dialysis, or chronic kidney inflammation, these drugs can cause tissue damage to the kidneys.
In brief, to increase awareness of drug-induced symptoms on the lungs, which may appear in patients as a result of using their medications as mentioned above and others, specifically Drug-Induced Interstitial Lung Disease (DIILD), we advise consulting the attending physician immediately upon feeling fatigue, shortness of breath, wheezing from the chest, and headache, due to the lungs’ inability to absorb sufficient oxygen. Carbon dioxide levels in the blood may rise, especially in patients who already have lung fibrosis, particularly during fast walking, climbing stairs, or physical exertion, while taking medications.
